Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Journal of Medicinal Chemistry2008Vol. 51(15), pp. 4790–4795
Citations Over TimeTop 10% of 2008 papers
Divya Krishnamurthy, Mark R. Karver, Edoardo Fiorillo, Valeria Orrù, Stephanie M. Stanford, Nunzio Bottini, Amy Barrios
Abstract
Gold(I) complexes containing N-heterocyclic carbene ligands were synthesized, characterized, and along with the antiarthritic drug, auranofin, tested as inhibitors of the cysteine-dependent protein tyrosine phosphatases, which are implicated in several disease states. These compounds exhibit potencies in the low micromolar range against the enzymes in vitro. At therapeutically relevant concentrations, all compounds inhibit PTP activity in Jurkat T leukemia cells with some selectivity. In addition, the gold-carbene compounds inhibit phosphatase activity in primary mouse thymocytes.
Related Papers
- → Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders(2023)113 cited
- → Gathering STYX: phosphatase-like form predicts functions for unique protein-interaction domains(1998)135 cited
- → Phosphorylation of Mycobacterium tuberculosis Ser/Thr Phosphatase by PknA and PknB(2011)49 cited
- → Phosphorylation of Ser 402 impedes phosphatase activity of slingshot 1(2011)27 cited
- → Phosphorylation of phosphatidate phosphatase on Ser 10 by protein kinase A regulates triacylglycerol synthesis in Saccharomyces cerevisiae(2012)